Carcinoma de paratiróide
Main Author: | |
---|---|
Publication Date: | 2005 |
Other Authors: | , , , , , |
Format: | Article |
Language: | por |
Source: | Repositório Institucional da UNIFESP |
Download full: | http://dx.doi.org/10.1590/S0004-27302005000500023 http://repositorio.unifesp.br/handle/11600/2736 |
Summary: | Parathyroid carcinoma is a rare condition, comprising less than 1% of the cases of primary hyperparathyroidism (PHP). Nonetheless, due to its aggressiveness, and having prognosis dependent on the precocity of diagnosis and radical therapeutic approach, it is paramount that the clinical suspicion be made before surgery. Clinical presentation is typical of severe PHP, with a parathyroid tumor >1.5cm, usually palpable. The pathologic features sometimes are difficult to characterize. Our experience with this condition (from 1983 to 2004) includes 7 cases, all symptomatic, hypercalcemic syndrome and bone disease present in most of them. In 6/7 the tumor was palpable, and in all the biochemical profile was compatible with severe PHP. Three patients died of complications of hypercalcemia. Recent findings point to a mutation on the gene HRPT2 as the molecular base for the development of this kind of tumor. The therapeutic approach is surgical and should include ipsilateral thyroidectomy and cervical exploration in order to find possible local metastasis. Post-surgical complications (mainly hypocalcemia) are proportional to the pre-existing metabolic alterations. The long-term prognosis depends upon the precocity of diagnosis, surgical success and control of hypercalcemia. New therapeutic approaches, based on bisphosphonates and calcimimetic drugs, as well as the possibility of genetic diagnosis, tend to ameliorate the prognosis of this severe affection. |
id |
UFSP_8aa5d4e45ee4724c47a7b96272ca96ab |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/2736 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Carcinoma de paratiróideParathyroid carcinomaParathyroid carcinomaPrimary hyperparathyroidismHypercalcemiaPTHCarcinoma de paratiróideHiperparatiroidismo primárioHipercalcemiaPTHParathyroid carcinoma is a rare condition, comprising less than 1% of the cases of primary hyperparathyroidism (PHP). Nonetheless, due to its aggressiveness, and having prognosis dependent on the precocity of diagnosis and radical therapeutic approach, it is paramount that the clinical suspicion be made before surgery. Clinical presentation is typical of severe PHP, with a parathyroid tumor >1.5cm, usually palpable. The pathologic features sometimes are difficult to characterize. Our experience with this condition (from 1983 to 2004) includes 7 cases, all symptomatic, hypercalcemic syndrome and bone disease present in most of them. In 6/7 the tumor was palpable, and in all the biochemical profile was compatible with severe PHP. Three patients died of complications of hypercalcemia. Recent findings point to a mutation on the gene HRPT2 as the molecular base for the development of this kind of tumor. The therapeutic approach is surgical and should include ipsilateral thyroidectomy and cervical exploration in order to find possible local metastasis. Post-surgical complications (mainly hypocalcemia) are proportional to the pre-existing metabolic alterations. The long-term prognosis depends upon the precocity of diagnosis, surgical success and control of hypercalcemia. New therapeutic approaches, based on bisphosphonates and calcimimetic drugs, as well as the possibility of genetic diagnosis, tend to ameliorate the prognosis of this severe affection.Carcinoma de paratiróide é uma condição rara, correspondendo na maior parte das casuísticas a menos de 1% dos casos de hiperparatiroidismo primário (HPP). No entanto, pela sua gravidade, e com o prognóstico dependente do diagnóstico precoce e de uma conduta agressiva, é fundamental que a suspeita clínica seja feita pré-operatoriamente. As características clínicas são compatíveis com um caso de HPP grave, sintomático, com tumor cervical >1,5cm, podendo ser palpável. A definição anátomo-patológica pode ser difícil em muitos casos. Nossa casuística (1983-2004) compreende 7 casos, todos sintomáticos, com síndrome hipercalcêmica e doença óssea presente na maioria. Em 6/7 o tumor era palpável, e todos apresentavam quadro bioquímico compatível. Três pacientes faleceram em quadro de hipercalcemia refratária. Dados recentes apontam para uma mutação no gene HRPT2 como base molecular para o desenvolvimento destes tumores. A conduta é cirúrgica e deve incluir hemitiroidectomia e exploração cervical ampliada, procurando focos metastáticos. O pós-operatório é compatível com a gravidade da alteração metabólica pré-existente, sendo comum a tendência a hipocalcemia. O prognóstico de longo prazo depende do diagnóstico precoce, do sucesso cirúrgico e do controle da hipercalcemia. Novas possibilidades terapêuticas, na forma de bisfosfonatos e drogas calcimiméticas, bem como a possibilidade de diagnóstico genético, tendem a melhorar o prognóstico desta grave condição.Escola Paulista de Medicina Serviço de Doenças Ósteo-MetabólicasInstituto FleuryUNIFESP, EPM, Serviço de Doenças Ósteo-MetabólicasSciELOSociedade Brasileira de Endocrinologia e MetabologiaUniversidade Federal de São Paulo (UNIFESP)Instituto FleuryVieira, José Gilberto H. [UNIFESP]Ohe, Monique Nakayama [UNIFESP]Hauache, Omar M.Oliveira, Ulisses Maia de [UNIFESP]Delana, Janaina Martins [UNIFESP]Gonçalves, André [UNIFESP]Lazaretti-Castro, Marise [UNIFESP]2015-06-14T13:31:47Z2015-06-14T13:31:47Z2005-10-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion811-815application/pdfhttp://dx.doi.org/10.1590/S0004-27302005000500023Arquivos Brasileiros de Endocrinologia & Metabologia. Sociedade Brasileira de Endocrinologia e Metabologia, v. 49, n. 5, p. 811-815, 2005.10.1590/S0004-27302005000500023S0004-27302005000500023.pdf0004-2730S0004-27302005000500023http://repositorio.unifesp.br/handle/11600/2736porArquivos Brasileiros de Endocrinologia & Metabologiainfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-05T14:35:04Zoai:repositorio.unifesp.br/:11600/2736Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-05T14:35:04Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
Carcinoma de paratiróide Parathyroid carcinoma |
title |
Carcinoma de paratiróide |
spellingShingle |
Carcinoma de paratiróide Vieira, José Gilberto H. [UNIFESP] Parathyroid carcinoma Primary hyperparathyroidism Hypercalcemia PTH Carcinoma de paratiróide Hiperparatiroidismo primário Hipercalcemia PTH |
title_short |
Carcinoma de paratiróide |
title_full |
Carcinoma de paratiróide |
title_fullStr |
Carcinoma de paratiróide |
title_full_unstemmed |
Carcinoma de paratiróide |
title_sort |
Carcinoma de paratiróide |
author |
Vieira, José Gilberto H. [UNIFESP] |
author_facet |
Vieira, José Gilberto H. [UNIFESP] Ohe, Monique Nakayama [UNIFESP] Hauache, Omar M. Oliveira, Ulisses Maia de [UNIFESP] Delana, Janaina Martins [UNIFESP] Gonçalves, André [UNIFESP] Lazaretti-Castro, Marise [UNIFESP] |
author_role |
author |
author2 |
Ohe, Monique Nakayama [UNIFESP] Hauache, Omar M. Oliveira, Ulisses Maia de [UNIFESP] Delana, Janaina Martins [UNIFESP] Gonçalves, André [UNIFESP] Lazaretti-Castro, Marise [UNIFESP] |
author2_role |
author author author author author author |
dc.contributor.none.fl_str_mv |
Universidade Federal de São Paulo (UNIFESP) Instituto Fleury |
dc.contributor.author.fl_str_mv |
Vieira, José Gilberto H. [UNIFESP] Ohe, Monique Nakayama [UNIFESP] Hauache, Omar M. Oliveira, Ulisses Maia de [UNIFESP] Delana, Janaina Martins [UNIFESP] Gonçalves, André [UNIFESP] Lazaretti-Castro, Marise [UNIFESP] |
dc.subject.por.fl_str_mv |
Parathyroid carcinoma Primary hyperparathyroidism Hypercalcemia PTH Carcinoma de paratiróide Hiperparatiroidismo primário Hipercalcemia PTH |
topic |
Parathyroid carcinoma Primary hyperparathyroidism Hypercalcemia PTH Carcinoma de paratiróide Hiperparatiroidismo primário Hipercalcemia PTH |
description |
Parathyroid carcinoma is a rare condition, comprising less than 1% of the cases of primary hyperparathyroidism (PHP). Nonetheless, due to its aggressiveness, and having prognosis dependent on the precocity of diagnosis and radical therapeutic approach, it is paramount that the clinical suspicion be made before surgery. Clinical presentation is typical of severe PHP, with a parathyroid tumor >1.5cm, usually palpable. The pathologic features sometimes are difficult to characterize. Our experience with this condition (from 1983 to 2004) includes 7 cases, all symptomatic, hypercalcemic syndrome and bone disease present in most of them. In 6/7 the tumor was palpable, and in all the biochemical profile was compatible with severe PHP. Three patients died of complications of hypercalcemia. Recent findings point to a mutation on the gene HRPT2 as the molecular base for the development of this kind of tumor. The therapeutic approach is surgical and should include ipsilateral thyroidectomy and cervical exploration in order to find possible local metastasis. Post-surgical complications (mainly hypocalcemia) are proportional to the pre-existing metabolic alterations. The long-term prognosis depends upon the precocity of diagnosis, surgical success and control of hypercalcemia. New therapeutic approaches, based on bisphosphonates and calcimimetic drugs, as well as the possibility of genetic diagnosis, tend to ameliorate the prognosis of this severe affection. |
publishDate |
2005 |
dc.date.none.fl_str_mv |
2005-10-01 2015-06-14T13:31:47Z 2015-06-14T13:31:47Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1590/S0004-27302005000500023 Arquivos Brasileiros de Endocrinologia & Metabologia. Sociedade Brasileira de Endocrinologia e Metabologia, v. 49, n. 5, p. 811-815, 2005. 10.1590/S0004-27302005000500023 S0004-27302005000500023.pdf 0004-2730 S0004-27302005000500023 http://repositorio.unifesp.br/handle/11600/2736 |
url |
http://dx.doi.org/10.1590/S0004-27302005000500023 http://repositorio.unifesp.br/handle/11600/2736 |
identifier_str_mv |
Arquivos Brasileiros de Endocrinologia & Metabologia. Sociedade Brasileira de Endocrinologia e Metabologia, v. 49, n. 5, p. 811-815, 2005. 10.1590/S0004-27302005000500023 S0004-27302005000500023.pdf 0004-2730 S0004-27302005000500023 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
Arquivos Brasileiros de Endocrinologia & Metabologia |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
811-815 application/pdf |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Endocrinologia e Metabologia |
publisher.none.fl_str_mv |
Sociedade Brasileira de Endocrinologia e Metabologia |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1841453702167134208 |